期刊文献+

腹腔镜子宫肌瘤剔除术后应用促性腺激素释放激素激动药预防子宫多发肌瘤复发 被引量:36

Preventive Recurrence of GnRH-a on Multiple Hysteromyoma After Laparoscopic Myomectomy
下载PDF
导出
摘要 目的分析腹腔镜下多发子宫肌瘤剔除术后应用促性腺激素释放激素激动药(GnRH-a)预防子宫多发肌瘤复发的效果。方法选取行腹腔镜子宫多发肌瘤剔除术患者148例,分为治疗组69例和对照组79例。两组均行腹腔镜下多发子宫肌瘤剔除术。治疗组术后皮下注射醋酸戈舍瑞林或曲谱瑞林或亮丙瑞林3.75 mg,间隔28 d,3~6次。随访2年观察其复发情况。比较两组术后复发情况。结果治疗组子宫体积在术后12,18,24个月均小于对照组(P<0.05或P<0.01)。治疗组术后18,24个月复发率低于对照组(P<0.05)。结论多发子宫肌瘤剔除术后用GnRH-a治疗对抑制子宫多发肌瘤复发有确切效果。 Objective To investigate preventive recurrence effect of GnRH-a on multiple hysteromyoma after laparoscopic myomectomy.Methods A total of 148 patients of multiple hysteromyoma were randomly divided into control group(n=79)and treatment group(n=69).Patients were given laparoscopic myomectomy,and patients in the treatment group were given 3.75 mg of goserelin acetate,triptorelin or leuprorelin for 3 to 6 times with an 28 d interval.Therapeutic effect was followed for 2 years and recurrence rate was compared between two groups.Results The uterine volume was significantly smaller in treatment group than control group(P<0.05)at 12th,18th and 24 th month after laparoscopic myomectomy(P<0.05).Recurrence rate was significantly lower in treatment group than control group at 18th and 24th months after laparoscopic myomectomy(P<0.05).Conclusion GnRH-a treatment is effective for reducing recurrence rate in multiple hysteromyoma patients after laparoscopic myomectomy.
作者 周琴 杨润峰 李莎 栗妍 ZHOU Qin;YANG Runfeng;LI Sha;LI Yan(Department of Obstetrics and Gynecology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Obstetrics and Gynecology,Hubei Cancer Hospital,Wuhan 430079,China;Department of Obstetrics and Gynecology,the Central Hospital of Wuhan City,Wuhan 430010,China)
出处 《医药导报》 CAS 北大核心 2018年第10期1217-1219,共3页 Herald of Medicine
基金 国家自然科学基金资助项目(81402161)
关键词 促性腺激素释放激素激动药 子宫多发肌瘤 腹腔镜子宫肌瘤剔除术 GnRH-a Multiple hysteromyoma Laparoscopic myomectomy
  • 相关文献

参考文献7

二级参考文献56

  • 1白文佩,李丽平,冯美英,王秀华,秦小琪,李克敏,周应芳.阴式与腹腔镜子宫全切除术的临床效果比较[J].中华妇产科杂志,2005,40(10):656-658. 被引量:50
  • 2Olive D L. Optimizing gonadotropin-releasing hormone agonisttherapy in women with endometriosis [J]. Treat Endocrinol,2004,3(2):83-89. 被引量:1
  • 3American Society for Reproductive Medicine. Revised AmericanSociety for reproductive medicine classification of endometriosis:1996[J]. Fertil Steril, 1997,67(5):817-821. 被引量:1
  • 4Kupperman H S, WetchierB B,Blatt M H. Contemporarytherapy of the menopausal syndrome[J]. J Am Med Ass, 1959,12(171):1627-1637. 被引量:1
  • 5Perry C M, Brogden R N. Goserelin:a review of itspharmacodynamic and pharmacokinetic properties andtherapeutic use in benign gynaecological disorders [J ]. Drugs,1996,54(4):379-346. 被引量:1
  • 6McLaren J S,Morris E,Rymer J. Gonadotrophin receptorhormone analogues in combination with add-back therapy:anupdate[J]. Menopause Int,2012,18(2):68-72. 被引量:1
  • 7Ross S M. Menopause: a standardized isoprepanolic blackcohosh extract (remifemin) is found to be safe and effective forin enopausal symptoms[J]. Holist Nurs Pract, 2012,26(1):58. 被引量:1
  • 8Filicori M,Hall DA,Loughlin JS,et al.A conservative approach to the management of uterine leiomyoma:pituitary desensibilization by luteinizing hormone releasing hormone analogue[J].Am J Obstet Gynecol,1983,147 (6):726-727. 被引量:1
  • 9Vercellini P,Crosignani PG,Mangioni C,et al.Treatment with gonadotrophin-releasing hormone agonists before hysterectomy for leiomyomas:results of a multicenter randomized controlled trial[J].Br J Obstet Gynaecol,1998,105 (11):1148-1154. 被引量:1
  • 10Di Lieto A,De Falco M,Staibano S,et al.Effects of gonadotropin-releasing hormone agonists on uterine volue and vasculature and on the immunohistochemical expression of basic fibroblast growth factor (bFGF) in uterine leiomyomas[J].Int J Gynecol Pathol,2003,22(4):353-358. 被引量:1

共引文献399

同被引文献320

引证文献36

二级引证文献221

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部